Wilson Sonsini Goodrich & Rosati advised General Atlantic on patent matters related to the transaction.Seaport Therapeutics (Seaport), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric…
Seaport Therapeutics’ $225 Million Series B Financing Round

























